Product Images Oxymorphone Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Oxymorphone Hydrochloride NDC 0115-1315 by Amneal Pharmaceuticals Of New York Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - oxymorphone hydrochloride extended release tablets 1

Chemical Structure - oxymorphone hydrochloride extended release tablets 1

PRINCIPAL DISPLAY PANEL - 40 mg Tablet Bottle Label - oxymorphone hydrochloride extended release tablets 10

PRINCIPAL DISPLAY PANEL - 40 mg Tablet Bottle Label - oxymorphone hydrochloride extended release tablets 10

Figure 1 - oxymorphone hydrochloride extended release tablets 2

Figure 1 - oxymorphone hydrochloride extended release tablets 2

Figure 2 - oxymorphone hydrochloride extended release tablets 3

Figure 2 - oxymorphone hydrochloride extended release tablets 3

PRINCIPAL DISPLAY PANEL - 5 mg Tablet Bottle Label - oxymorphone hydrochloride extended release tablets 4

PRINCIPAL DISPLAY PANEL - 5 mg Tablet Bottle Label - oxymorphone hydrochloride extended release tablets 4

This is a medication label for twice-daily extended-release tablets of oxymorphone hydrochloride, 5 mg strength. The NDC code is 0115-1231-01, and the prescription is only available to be dispensed by a pharmacist. Patients should receive the medication guide along with the 100 tablets. The remaining text appears to be a mix of random alphanumeric characters and is not relevant to the medication description.*

PRINCIPAL DISPLAY PANEL - 7.5 mg Tablet Bottle Label - oxymorphone hydrochloride extended release tablets 5

PRINCIPAL DISPLAY PANEL - 7.5 mg Tablet Bottle Label - oxymorphone hydrochloride extended release tablets 5

This is a prescription medicine called Oxymorphone Hydrochloride (7.5mg, Extended-Release Tablets, USP). The medication needs to be taken twice a day, 12 hours apart. The NDC number for this medication is 0115-1315-01. The medicine comes in a package that has 100 tablets. If you are a pharmacist, it is important to dispense the medication guide to each patient.*

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label - oxymorphone hydrochloride extended release tablets 6

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label - oxymorphone hydrochloride extended release tablets 6

This is a description of the prescription drug Oxymorphone Hydrochloride Extended-Release tablets, with an NDC number of 0115-1232-01 and a strength of 10 mg. The suggested dosage is twice daily, every 12 hours. The text includes a warning to pharmacists to dispense the Medication Guide to each patient. The rest of the text appears to be gibberish or nonsense characters and is not relevant to the drug's description.*

PRINCIPAL DISPLAY PANEL - 15 mg Tablet Bottle Label - oxymorphone hydrochloride extended release tablets 7

PRINCIPAL DISPLAY PANEL - 15 mg Tablet Bottle Label - oxymorphone hydrochloride extended release tablets 7

PRINCIPAL DISPLAY PANEL - 20 mg Tablet Bottle Label - oxymorphone hydrochloride extended release tablets 8

PRINCIPAL DISPLAY PANEL - 20 mg Tablet Bottle Label - oxymorphone hydrochloride extended release tablets 8

This is a prescription drug information sheet for Oxymorphone Hydrochloride Extended-Release Tablets. Each bottle has 100 Tablets with a strength of 20mg, and should be taken twice a day, every 12 hours. The unique NDC number for this drug is 0115-1233-01. The package should have a Medication Guide leaflet for patients. Any other information is not readable due to errors.*

PRINCIPAL DISPLAY PANEL - 30 mg Tablet Bottle Label - oxymorphone hydrochloride extended release tablets 9

PRINCIPAL DISPLAY PANEL - 30 mg Tablet Bottle Label - oxymorphone hydrochloride extended release tablets 9

This is a prescription medication, NDC 0115-1317-01. The tablets contain 30 mg of extended-release Oxymorphone hydrochloride. The suggested dosage is twice a day, every 12 hours. The pharmacist is advised to dispense the medication guide to each patient.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.